Indication CINRYZE® (C1 esterase inhibitor [human]) is indicated for routine prophylaxis against angioedema attacks in adults, adolescents and pediatric patients (6 years of age and older) with Hereditary Angioedema (HAE).
![CINRYZE® (C1 esterase inhibitor [human]) Logo](/dist/images/hdr-log3.webp)
![CINRYZE® (C1 esterase inhibitor [human]) Logo](/dist/images/hdr-logo2.webp){kind=logo}
CINRYZE Resources
Not real patients.
Materials for healthcare professionals
Path to Independence Brochure
Print this guide to learn more about the Path to Independence program and self-administration training for your eligible CINRYZE patients.
Materials for patients and caregivers
HAE Doctor Discussion Guide
Print this guide to encourage discussion with patients and their caregivers about HAE symptoms and the tests needed to confirm an HAE diagnosis.
HAE Family Health Tree worksheet
Help patients understand that HAE can affect the whole family by encouraging them to track their family's health history.
CINRYZE Patient brochure
This overview of CINRYZE can help patients understand how CINRYZE works, whether a C1-INH preventive therapy might be right for them, and what to expect from therapy.
Path to Independence™ brochure
Share this patient-friendly version of the brochure to provide details about the free services available through the program, including infusion training for eligible patients who are starting self-administration with CINRYZE.
HAE Attack Plan letter
This letter can be filled out by patients and distributed to appropriate individuals (extended family, bosses, teachers, coaches, etc.) in the event that he or she has an HAE attack.
Caring for Someone with HAE Brochure
Patients can find helpful information and resources to help support a loved one with HAE and learn about the important role of being a caregiver.
CINRYZE Self-Administration Instructions
After you teach patients how to self-administer CINRYZE therapy, share this brochure which features step-by-step illustrated instructions, for additional at-home support.
Takeda advises the patient to receive training from a healthcare professional prior to self-administration.Takeda advises the patient and/or caregiver(s) to receive training from a healthcare professional prior to self-administration.
You might also be interested in:
